Two Sigma Investments, LP Agile Therapeutics Inc Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.21 - $0.31 $61 - $91
-295 Reduced 2.85%
10,069 $2,000
Q4 2022

Feb 14, 2023
SELL
$0.18 - $0.28 $3,162 - $4,919
-17,568 Reduced 62.9%
10,364 $2,000
Q3 2022

Nov 14, 2022
SELL
$0.28 - $0.72 $4,896 - $12,592
-17,489 Reduced 38.5%
27,932 $8,000
Q2 2022

Aug 15, 2022
BUY
$1.09 - $8.24 $49,508 - $374,269
45,421 New
45,421 $53,000

About AGILE THERAPEUTICS INC

AGRX Quotes by TradingView
  • Ticker AGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 39,023,000
  • Market Cap $55.4M
  • Description
  • Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...
More about AGRX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email